Table 2.
Pharmacokinetic parameters for urinary excretion of formoterol enantiomers and their glucuronide conjugates following an oral dose of rac-formoterol (60 µg formoterol fumarate dihydrate). (Data are median and range for six male volunteers).
(R; R)-formoterol | (S; S)-formoterol | (R; R)-glucuronide | (S; S)-glucuronide | |||||
---|---|---|---|---|---|---|---|---|
Median | Range | Median | Range | Median | Range | Median | Range | |
ERmax (nmol h−1) | 0.74 | 0.35–1.26 | 1.36 | 0.94–2.12 | 12.5 | 4.53–18.1 | 4.85 | 1.66–9.44 |
tmaxR (h) | 1.5 | 0.5–2.5 | 1.5 | 0.5–2.5 | 1.5 | 0.5–2.5 | 1.5 | 0.5–2.5 |
t1/2(2,8 h) (h) | 2.9 | 1.0–5.8 | 2.7 | 1.1–3.2 | 1.2 | 0.9–1.7 | 1.4 | 0.8–2.4 |
Ae (0–8 h) (% of dose) | 2.07 | 0.97–2.89 | 3.49 | 2.56–3.76 | 21.0 | 13.1–31.0 | 10.3 | 4.23–14.6 |